![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Biol Chem, Vol. 275, Issue 19, 14005-14008, May 12, 2000
From the Suppressor of cytokine signaling-1 (SOCS1) is an
inducible Src homology 2 (SH2)-containing protein that negatively
regulates cytokine and growth factor signaling required during thymic
development. Recent evidence indicates that SOCS1 interacts with
elongins B and C, which are components of a ubiquitin ligase complex,
VCB (VHL/elonginC/B), based on the VHL (von
Hippel Lindau) tumor suppressor protein. SOCS1 has previously been
shown to operate as an inhibitor of Janus kinases. Here we show that
SOCS1 has the distinct function of targeting the hematopoietic specific
guanine nucleotide exchange factor, VAV, for ubiquitin-mediated protein
degradation. VAV and SOCS1 form a protein complex through interactions
between the VAV NH2-terminal regulatory region and
the SH2 domain of SOCS1 in a phosphotyrosine-independent manner. SOCS1
decreases the steady state levels of cotransfected VAV and onco-VAV and
reduces the focus forming activity of onco-VAV. SOCS1 stimulates the
polyubiquitination of VAV proteins in vivo, which was
stabilized by proteasomal inhibitors. These results suggest that SOCS1
programs VAV degradation by acting as a substrate-specific recognition
component of a VCB-like ubiquitin ligase complex.
ACCELERATED PUBLICATION
Suppressor of Cytokine Signaling-1 Inhibits VAV Function
through Protein Degradation*
§¶,
§
, and
**
Ontario Cancer Institute, Princess Margaret
Hospital, 610 University Avenue, Toronto ON M5G 2M9, Canada and
** Department of Immunology and Medical Biophysics and Department of
Medicine, University of Toronto, Toronto, M5G 2M9 Canada
*
This work was supported by grants from the Medical Research
Council of Canada (MRC) and the National Cancer Institute of Canada. The costs of publication of this article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by an MRC postdoctoral fellowship.

Senior Research Scholar of the Arthritis Society of Canada. To
whom correspondence should be addressed. Tel.: 416-946-2233; Fax:
416-946-2984; E-mail: Rottapel@oci.utoronto.ca.
This article has been cited by other articles:
![]() |
S. Madonna, C. Scarponi, O. De Pita, and C. Albanesi Suppressor of cytokine signaling 1 inhibits IFN-{gamma} inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation FASEB J, September 1, 2008; 22(9): 3287 - 3297. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Haffner, A. Jurgeit, C. Berlato, S. Geley, N. Parajuli, A. Yoshimura, and W. Doppler Interaction and Functional Interference of Glucocorticoid Receptor and SOCS1 J. Biol. Chem., August 8, 2008; 283(32): 22089 - 22096. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-R. Yu, R. M. Mahdi, X. Liu, A. Zhang, T. Naka, T. Kishimoto, and C. E. Egwuagu SOCS1 Regulates CCR7 Expression and Migration of CD4+ T Cells into Peripheral Tissues J. Immunol., July 15, 2008; 181(2): 1190 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mottok, C. Renne, K. Willenbrock, M.-L. Hansmann, and A. Brauninger Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6 Blood, November 1, 2007; 110(9): 3387 - 3390. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boyle, P. Egan, S. Rakar, T. A. Willson, I. P. Wicks, D. Metcalf, D. J. Hilton, N. A. Nicola, W. S. Alexander, A. W. Roberts, et al. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo Blood, September 1, 2007; 110(5): 1466 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Debrincat, J.-G. Zhang, T. A. Willson, J. Silke, L. M. Connolly, R. J. Simpson, W. S. Alexander, N. A. Nicola, B. T. Kile, and D. J. Hilton Ankyrin Repeat and Suppressors of Cytokine Signaling Box Protein Asb-9 Targets Creatine Kinase B for Degradation J. Biol. Chem., February 16, 2007; 282(7): 4728 - 4737. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-i. Seki, J. Yang, M. Okamoto, S. Tanaka, R. Goitsuka, M. A. Farrar, and M. Kubo IL-7/STAT5 Cytokine Signaling Pathway Is Essential but Insufficient for Maintenance of Naive CD4 T Cell Survival in Peripheral Lymphoid Organs J. Immunol., January 1, 2007; 178(1): 262 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Piessevaux, D. Lavens, T. Montoye, J. Wauman, D. Catteeuw, J. Vandekerckhove, D. Belsham, F. Peelman, and J. Tavernier Functional Cross-modulation between SOCS Proteins Can Stimulate Cytokine Signaling J. Biol. Chem., November 3, 2006; 281(44): 32953 - 32966. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Flores-Morales, C. J. Greenhalgh, G. Norstedt, and E. Rico-Bautista Negative Regulation of Growth Hormone Receptor Signaling Mol. Endocrinol., February 1, 2006; 20(2): 241 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Inagaki-Ohara, A Sasaki, G Matsuzaki, T Ikeda, M Hotokezaka, K Chijiiwa, M Kubo, H Yoshida, Y Nawa, and A Yoshimura Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice Gut, February 1, 2006; 55(2): 212 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ben-Zvi, A. Yayon, A. Gertler, and E. Monsonego-Ornan Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling J. Cell Sci., January 15, 2006; 119(2): 380 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Richardson and W. Zundel The Emerging Role of the COP9 Signalosome in Cancer Mol. Cancer Res., December 1, 2005; 3(12): 645 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Tannahill, J. Elliott, A. C. Barry, L. Hibbert, N. A. Cacalano, and J. A. Johnston SOCS2 Can Enhance Interleukin-2 (IL-2) and IL-3 Signaling by Accelerating SOCS3 Degradation Mol. Cell. Biol., October 15, 2005; 25(20): 9115 - 9126. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sommer, C. Schmid, R. M. Sobota, U. Lehmann, N. J. Stevenson, J. A. Johnston, F. Schaper, P. C. Heinrich, and S. Haan Mechanisms of SOCS3 Phosphorylation upon Interleukin-6 Stimulation: CONTRIBUTIONS OF Src- AND RECEPTOR-TYROSINE KINASES J. Biol. Chem., September 9, 2005; 280(36): 31478 - 31488. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Forget, D. J. Gregory, and M. Olivier Proteasome-mediated Degradation of STAT1{alpha} following Infection of Macrophages with Leishmania donovani J. Biol. Chem., August 26, 2005; 280(34): 30542 - 30549. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, Z. Li, E. M. Messing, and G. Wu The SPRY Domain-containing SOCS Box Protein 1 (SSB-1) Interacts with MET and Enhances the Hepatocyte Growth Factor-induced Erk-Elk-1-Serum Response Element Pathway J. Biol. Chem., April 22, 2005; 280(16): 16393 - 16401. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kario, M. D. Marmor, K. Adamsky, A. Citri, I. Amit, N. Amariglio, G. Rechavi, and Y. Yarden Suppressors of Cytokine Signaling 4 and 5 Regulate Epidermal Growth Factor Receptor Signaling J. Biol. Chem., February 25, 2005; 280(8): 7038 - 7048. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Nicholson, D. Metcalf, N. S. Sprigg, R. Columbus, F. Walker, A. Silva, D. Cary, T. A. Willson, J.-G. Zhang, D. J. Hilton, et al. Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling PNAS, February 15, 2005; 102(7): 2328 - 2333. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mostecki, B. M. Showalter, and P. B. Rothman Early Growth Response-1 Regulates Lipopolysaccharide-induced Suppressor of Cytokine Signaling-1 Transcription J. Biol. Chem., January 28, 2005; 280(4): 2596 - 2605. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Qing, A. P. Costa-Pereira, D. Watling, and G. R. Stark Role of Tyrosine 441 of Interferon-{gamma} Receptor Subunit 1 in SOCS-1-mediated Attenuation of STAT1 Activation J. Biol. Chem., January 21, 2005; 280(3): 1849 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kamura, K. Maenaka, S. Kotoshiba, M. Matsumoto, D. Kohda, R. C. Conaway, J. W. Conaway, and K. I. Nakayama VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases Genes & Dev., December 15, 2004; 18(24): 3055 - 3065. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Q. Vuong, T. L. Arenzana, B. M. Showalter, J. Losman, X. P. Chen, J. Mostecki, A. S. Banks, A. Limnander, N. Fernandez, and P. B. Rothman SOCS-1 Localizes to the Microtubule Organizing Complex-Associated 20S Proteasome Mol. Cell. Biol., October 15, 2004; 24(20): 9092 - 9101. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Beslu, J. Krosl, M. Laurin, N. Mayotte, K. R. Humphries, and G. Sauvageau Molecular interactions involved in HOXB4-induced activation of HSC self-renewal Blood, October 15, 2004; 104(8): 2307 - 2314. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wilcox, K. D. Katsanakis, F. Bheda, and T. S. Pillay Asb6, an Adipocyte-specific Ankyrin and SOCS Box Protein, Interacts with APS to Enable Recruitment of Elongins B and C to the Insulin Receptor Signaling Complex J. Biol. Chem., September 10, 2004; 279(37): 38881 - 38888. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Sitko, C. I. Guevara, and N. A. Cacalano Tyrosine-phosphorylated SOCS3 Interacts with the Nck and Crk-L Adapter Proteins and Regulates Nck Activation J. Biol. Chem., September 3, 2004; 279(36): 37662 - 37669. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ueki, T. Kondo, and C. R. Kahn Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms Mol. Cell. Biol., June 15, 2004; 24(12): 5434 - 5446. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Johnston Are SOCS suppressors, regulators, and degraders? J. Leukoc. Biol., May 1, 2004; 75(5): 743 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Goldshmit, C. E. Walters, H. J. Scott, C. J. Greenhalgh, and A. M. Turnley SOCS2 Induces Neurite Outgrowth by Regulation of Epidermal Growth Factor Receptor Activation J. Biol. Chem., April 16, 2004; 279(16): 16349 - 16355. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Katzav Vav1: an oncogene that regulates specific transcriptional activation of T cells Blood, April 1, 2004; 103(7): 2443 - 2451. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ilangumaran, D. Finan, J. Raine, and R. Rottapel Suppressor of Cytokine Signaling 1 Regulates an Endogenous Inhibitor of a Mast Cell Protease J. Biol. Chem., October 24, 2003; 278(43): 41871 - 41880. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miura-Shimura, L. Duan, N. L. Rao, A. L. Reddi, H. Shimura, R. Rottapel, B. J. Druker, A. Tsygankov, V. Band, and H. Band Cbl-mediated Ubiquitinylation and Negative Regulation of Vav J. Biol. Chem., October 3, 2003; 278(40): 38495 - 38504. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ilangumaran, S. Ramanathan, J. La Rose, P. Poussier, and R. Rottapel Suppressor of Cytokine Signaling 1 Regulates IL-15 Receptor Signaling in CD8+CD44high Memory T Lymphocytes J. Immunol., September 1, 2003; 171(5): 2435 - 2445. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Haan, P. Ferguson, U. Sommer, M. Hiremath, D. W. McVicar, P. C. Heinrich, J. A. Johnston, and N. A. Cacalano Tyrosine Phosphorylation Disrupts Elongin Interaction and Accelerates SOCS3 Degradation J. Biol. Chem., August 22, 2003; 278(34): 31972 - 31979. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. YANG and X. YU Regulation of apoptosis: the ubiquitous way FASEB J, May 1, 2003; 17(8): 790 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-W. Min, J.-W. Hwang, J.-S. Lee, Y. Park, T.-a. Tamura, and J.-B. Yoon TIP120A Associates with Cullins and Modulates Ubiquitin Ligase Activity J. Biol. Chem., April 25, 2003; 278(18): 15905 - 15910. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Losman, X. P. Chen, B. Q. Vuong, S. Fay, and P. B. Rothman Protein Phosphatase 2A Regulates the Stability of Pim Protein Kinases J. Biol. Chem., February 7, 2003; 278(7): 4800 - 4805. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Giordanetto and R. T. Kroemer A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1) Protein Eng. Des. Sel., February 1, 2003; 16(2): 115 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, M. Komiya, K. Sone, E. Hirose, N. Gotoh, H. Morii, Y. Ohta, and N. Mori Grit, a GTPase-Activating Protein for the Rho Family, Regulates Neurite Extension through Association with the TrkA Receptor and N-Shc and CrkL/Crk Adapter Molecules Mol. Cell. Biol., December 15, 2002; 22(24): 8721 - 8734. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ilangumaran, D. Finan, J. La Rose, J. Raine, A. Silverstein, P. De Sepulveda, and R. Rottapel A Positive Regulatory Role for Suppressor of Cytokine Signaling 1 in IFN-{gamma}-Induced MHC Class II Expression in Fibroblasts J. Immunol., November 1, 2002; 169(9): 5010 - 5020. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rui, M. Yuan, D. Frantz, S. Shoelson, and M. F. White SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2 J. Biol. Chem., October 25, 2002; 277(44): 42394 - 42398. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. W. Chong, H. E. Thomas, and T. W. H. Kay Suppressor of Cytokine Signaling-1 Regulates the Sensitivity of Pancreatic beta Cells to Tumor Necrosis Factor J. Biol. Chem., July 26, 2002; 277(31): 27945 - 27952. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Krebs, R. T. Uren, D. Metcalf, S. Rakar, J.-G. Zhang, R. Starr, D. P. De Souza, K. Hanzinikolas, J. Eyles, L. M. Connolly, et al. SOCS-6 Binds to Insulin Receptor Substrate 4, and Mice Lacking the SOCS-6 Gene Exhibit Mild Growth Retardation Mol. Cell. Biol., July 1, 2002; 22(13): 4567 - 4578. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schmidt and A. Hall Guanine nucleotide exchange factors for Rho GTPases: turning on the switch Genes & Dev., July 1, 2002; 16(13): 1587 - 1609. [Full Text] [PDF] |
||||
![]() |
D. Ungureanu, P. Saharinen, I. Junttila, D. J. Hilton, and O. Silvennoinen Regulation of Jak2 through the Ubiquitin-Proteasome Pathway Involves Phosphorylation of Jak2 on Y1007 and Interaction with SOCS-1 Mol. Cell. Biol., May 15, 2002; 22(10): 3316 - 3326. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rao, I. Dodge, and H. Band The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system J. Leukoc. Biol., May 1, 2002; 71(5): 753 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Glickman and A. Ciechanover The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction Physiol Rev, April 1, 2002; 82(2): 373 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-G. Zhang, D. Metcalf, S. Rakar, M. Asimakis, C. J. Greenhalgh, T. A. Willson, R. Starr, S. E. Nicholson, W. Carter, W. S. Alexander, et al. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action invivo PNAS, October 16, 2001; (2001) 231486498. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Krebs and D. J. Hilton SOCS Proteins: Negative Regulators of Cytokine Signaling Stem Cells, September 1, 2001; 19(5): 378 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-P. Gulli and M. Peter Temporal and spatial regulation of Rho-type guanine-nucleotide exchange factors: the yeast perspective Genes & Dev., February 15, 2001; 15(4): 365 - 379. [Full Text] |
||||
![]() |
A. S. K. de Hooge, F. A. J. van de Loo, O. J. Arntz, and W. B. van den Berg Involvement of IL-6, Apart from Its Role in Immunity, in Mediating a Chronic Response during Experimental Arthritis Am. J. Pathol., December 1, 2000; 157(6): 2081 - 2091. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kamura, S. Sato, K. Iwai, M. Czyzyk-Krzeska, R. C. Conaway, and J. W. Conaway Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex PNAS, September 5, 2000; (2000) 190332597. [Abstract] [Full Text] |
||||
![]() |
D. Fang, H.-Y. Wang, N. Fang, Y. Altman, C. Elly, and Y.-C. Liu Cbl-b, a RING-type E3 Ubiquitin Ligase, Targets Phosphatidylinositol 3-Kinase for Ubiquitination in T Cells J. Biol. Chem., February 9, 2001; 276(7): 4872 - 4878. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kamizono, T. Hanada, H. Yasukawa, S. Minoguchi, R. Kato, M. Minoguchi, K. Hattori, S. Hatakeyama, M. Yada, S. Morita, et al. The SOCS Box of SOCS-1 Accelerates Ubiquitin-dependent Proteolysis of TEL-JAK2 J. Biol. Chem., April 13, 2001; 276(16): 12530 - 12538. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Bourette, P. De Sepulveda, S. Arnaud, P. Dubreuil, R. Rottapel, and G. Mouchiroud Suppressor of Cytokine Signaling 1 Interacts with the Macrophage Colony-stimulating Factor Receptor and Negatively Regulates Its Proliferation Signal J. Biol. Chem., June 15, 2001; 276(25): 22133 - 22139. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kamura, D. Burian, Q. Yan, S. L. Schmidt, W. S. Lane, E. Querido, P. E. Branton, A. Shilatifard, R. C. Conaway, and J. W. Conaway MUF1, A Novel Elongin BC-interacting Leucine-rich Repeat Protein That Can Assemble with Cul5 and Rbx1 to Reconstitute a Ubiquitin Ligase J. Biol. Chem., August 3, 2001; 276(32): 29748 - 29753. [Abstract] [Full Text] [PDF] |
||||
|
|